500 mg氟维司群治疗既往接受芳香化酶抑制剂治疗的复发转移性乳腺癌患者的回顾性研究
赵燕南,龚成成,胡夕春,等
A retrospective study of 500 mg fulvestrant in recurrent or metastatic breast cancer patients pretreated with the third generation of aromatase inhibitors
ZHAO Yannan, GONG Chengcheng, HU Xichun, et al
中国癌症杂志
.
2016, (9): 777
-783
.
DOI: 10.19401/j.cnki.1007-3639.2016.09.009
